Fentanyl (FEN) antibody and antigen (hapten, BSA/OVA conjugated)

Diagnostic anti-Fentanyl (FEN) antibodies (anti-Fentanyl, anti-FEN) and diagnostic hapten-carrier conjugates BSA-Fentanyl (FEN), OVA-Fentanyl (FEN), KLH-Fentanyl (FEN) antigens for Pain FEN detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Pain diagnostics products collection>>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-232-Ag01BSA-Fentanyl (FEN)$756.00
GMP-SMT-232-Ag02OVA-Fentanyl (FEN)$756.00
GMP-SMT-232-Ab01Anti-human Fentanyl (FEN) mouse monoclonal antibody (mAb)$1953.00
GMP-SMT-232-Ab02Anti-human Fentanyl (FEN) human monoclonal antibody (mAb)$1953.00

Size: 1mg | 10mg | 100mg



Product Description

BSA-Fentanyl (FEN)

Cat No.GMP-SMT-232-Ag01
Product NameBSA-Fentanyl (FEN)
TargetFentanyl (FEN)
Expression platformSynthetic
Bioactivity validationFentanyl (FEN) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in FEN level test of Pain and related syndrome evaluation
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Fentanyl (FEN) / OVA-Fentanyl (FEN) is Synthetic.
PurityHigh (TBD)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

OVA-Fentanyl (FEN)

Cat No.GMP-SMT-232-Ag02
Product NameOVA-Fentanyl (FEN)
TargetFentanyl (FEN)
Expression platformSynthetic
Bioactivity validationFentanyl (FEN) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in FEN level test of Pain and related syndrome evaluation
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Fentanyl (FEN) / OVA-Fentanyl (FEN) is Synthetic.
PurityHigh (TBD)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Anti-human Fentanyl (FEN) mouse monoclonal antibody (mAb)

Cat No.GMP-SMT-232-Ab01
Product NameAnti-human Fentanyl (FEN) mouse monoclonal antibody (mAb)
TargetFentanyl (FEN)
Expression platformhybridoma
IsotypesMouse IgG
Bioactivity validationFentanyl (FEN) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Fentanyl (FEN) antibodies in FEN level test of Pain and related syndrome evaluation.
TagmFc
Products descriptionAnti-human Fentanyl (FEN) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology.
PurityHigh (TBD)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Anti-human Fentanyl (FEN) human monoclonal antibody (mAb)

Cat No.GMP-SMT-232-Ab02
Product NameAnti-human Fentanyl (FEN) human monoclonal antibody (mAb)
TargetFentanyl (FEN)
Expression platformhybridoma
IsotypesHuman IgG1
Bioactivity validationFentanyl (FEN) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Fentanyl (FEN) antibodies in FEN level test of Pain and related syndrome evaluation.
TaghFc
Products descriptionAnti-human Fentanyl (FEN) mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO.
PurityPurity: ≥95% (SDS-PAGE)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationSupplied as a 0.2 μM filtered solution of PBS, PH7.4.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Target/Biomarker information


    Serial Number 1: Fentanyl and Its Role in In Vitro Diagnosis (IVD)

    Fentanyl, a synthetic opioid of immense potency, assumes a pivotal role in the realm of in vitro diagnosis (IVD). Our biopharmaceutical company, Genemedi, stands at the forefront of offering specialized tools to enable precise and sensitive detection of Fentanyl across diverse sample matrices. These encompass anti-Fentanyl antibodies and an extensive repertoire of small molecule competitive antigens, including Carrier-coupled antigens, immunogens, hapten-carrier conjugates, Bovine Serum Albumin (BSA)-conjugated, and Ovalbumin (OVA)-conjugated variants. These meticulously engineered reagents serve as indispensable assets for professionals in the fields of clinical diagnostics, forensic investigations, pharmacokinetic research, workplace safety, and public health surveillance.

    Serial Number 2: The Significance of Measuring Fentanyl

    a. Clinical Management: Fentanyl's role in clinical settings predominantly revolves around pain management. It is widely used for alleviating moderate to severe pain, often administered in various forms such as transdermal patches, lozenges, and injections. Measuring Fentanyl levels in patients undergoing pain management regimens is of paramount importance. It allows healthcare providers to ascertain the therapeutic efficacy of Fentanyl, ensuring that the patient's pain is adequately controlled while minimizing the risk of overdose. The precise quantification of Fentanyl in biological samples empowers clinicians to fine-tune dosage adjustments, tailor treatment plans, and optimize pain control strategies for individual patients.

    b. Forensic Investigations: Fentanyl, known for its remarkable potency, has gained notoriety in cases of drug abuse and overdose. In forensic investigations, the accurate measurement of Fentanyl assumes a critical role. It aids forensic experts and law enforcement agencies in determining the presence of Fentanyl in biological specimens, facilitating the elucidation of drug-related incidents and contributing to the gathering of crucial evidence. Whether it involves post-mortem examinations or the analysis of bodily fluids in criminal cases, Fentanyl testing is indispensable in unveiling the truth behind drug-related fatalities and criminal activities.

    c. Drug Compliance and Occupational Safety: The significance of measuring Fentanyl extends beyond clinical and forensic domains. In occupational settings where safety is paramount, particularly in industries such as transportation, heavy machinery operation, and law enforcement, ensuring sobriety and adherence to drug-free policies is critical. Workplace drug testing programs often include Fentanyl testing to confirm that employees are complying with safety regulations. It is a vital component of maintaining high safety standards, protecting both employees and the public from potential hazards associated with impaired individuals operating heavy machinery or performing safety-sensitive tasks.

    d. Pharmacokinetic Research: Researchers engaged in pharmacokinetic studies find Fentanyl measurement to be an indispensable tool. These studies delve into the absorption, distribution, metabolism, and excretion (ADME) dynamics of Fentanyl within the human body. The meticulous measurement of Fentanyl levels provides valuable insights into its pharmacokinetic profile. Researchers can track how Fentanyl is absorbed after administration, how it is distributed in various tissues, how it undergoes metabolism, and how it is eventually eliminated from the body. This information is vital for drug development and optimization, allowing pharmaceutical companies to formulate safe and effective Fentanyl-based medications and understand their behavior within the human body.

    e. Public Health Surveillance: The opioid epidemic has placed a spotlight on the need for comprehensive public health surveillance of opioid use, including Fentanyl. Monitoring Fentanyl levels within communities is instrumental in tracking and responding to opioid abuse trends. Public health organizations and authorities rely on data regarding Fentanyl presence to craft targeted interventions, formulate evidence-based policies, and allocate resources effectively to combat the opioid crisis. By monitoring Fentanyl, healthcare professionals and policymakers can gain valuable insights into the prevalence of Fentanyl use, the emergence of new analogs, and the geographical distribution of Fentanyl-related incidents. This data-driven approach aids in preventing overdose deaths, addressing addiction, and reducing the societal impact of opioid abuse.

    In conclusion, the precise quantification of Fentanyl holds multifaceted significance across various domains, encompassing clinical management, forensic science, workplace safety, pharmacokinetic research, and public health surveillance. Genemedi's specialized anti-Fentanyl antibodies and competitive antigens play a pivotal role in facilitating accurate Fentanyl detection, ultimately contributing to improved patient care, safety, scientific research, and public health initiatives.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.